Pharmaceutical Executive August 12, 2024
The latest news for pharma industry insiders.
Getting Unstuck on the Path to Digital Transformation
The transition to AI and machine learning was well underway long before ChatGPT burst onto the marketplace; however, organizations were, and still are, constrained by data challenges.
FDA Approves First Nasal Spray for Anaphylaxis
The FDA approved neffy (ARS Pharmaceuticals), an epinephrine nasal spray for the emergency treatment of allergic reactions, including anaphylaxis, for adults and pediatric individuals who weigh at least 30 kg. This marks the first approval for a nasal spray for the treatment of anaphylaxis, according to the agency.
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Merck will acquire full global rights to clinical-stage bispecific antibody CN201 from...
Today's Sponsors
Today's Sponsor